ProQR Therapeutics Ownership | Who Owns ProQR Therapeutics?

ProQR Therapeutics Ownership Summary

ProQR Therapeutics is owned by 38.42% institutional investors, 18.04% insiders, and 43.54% retail investors. Privium fund management b.v. is the largest institutional shareholder, holding 6.84% of PRQR shares. abrdn World Healthcare is the top mutual fund, with 1.76% of its assets in ProQR Therapeutics shares.

PRQR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ProQR Therapeutics	38.42%	18.04%	43.54%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Privium fund management b.v.	5.58M	6.84%	$9.21M
Adage capital partners gp	6.60M	6.27%	$13.47M
Woodline partners lp	3.56M	4.36%	$9.43M
Millennium management	2.83M	3.46%	$7.49M
Affinity asset advisors	3.50M	3.32%	$7.14M
Ubs group	2.31M	2.83%	$6.12M
Sio capital management	2.08M	1.97%	$4.23M
Abrdn	1.85M	1.76%	$3.77M
Kynam capital management, lp	1.65M	1.57%	$3.36M
Dafna capital management	1.57M	1.49%	$3.20M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
M28 capital management lp	1.02M	3.55%	$2.08M
Privium fund management b.v.	5.58M	2.35%	$9.21M
Sio capital management	2.08M	1.62%	$4.23M
Affinity asset advisors	3.50M	0.97%	$7.14M
Dafna capital management	1.57M	0.88%	$3.20M
Ghost tree capital	900.00K	0.47%	$1.49M
Kynam capital management, lp	1.65M	0.36%	$3.36M
Ikarian capital	868.07K	0.34%	$1.77M
Platinum investment management	1.45M	0.20%	$2.96M
Monaco asset management sam	460.00K	0.16%	$938.40K

Top Buyers

Holder	Shares	% Assets	Change
Woodline partners lp	3.56M	0.06%	3.56M
Millennium management	2.83M	0.00%	2.68M
Ubs group	2.31M	0.00%	2.31M
Ghost tree capital	900.00K	0.47%	900.00K
Ikarian capital	868.07K	0.34%	868.07K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-1.84M
Adage capital partners gp	6.60M	0.02%	-1.50M
Altium capital management lp	-	-	-575.00K
Schonfeld strategic advisors	-	-	-412.19K
Ubs oconnor	-	-	-227.02K

New Positions

Holder	Shares	% Assets	Change	Value
Woodline partners lp	3.56M	0.06%	3.56M	$9.43M
Ghost tree capital	900.00K	0.47%	900.00K	$1.49M
Ikarian capital	868.07K	0.34%	868.07K	$1.77M
Cubist systematic strategies	133.69K	0.00%	133.69K	$354.28K
Velan capital investment management lp	40.50K	0.09%	40.50K	$107.33K

Sold Out

Holder	Change
Qube research	-33.00
Concord wealth partners	-444.00
Lindbrook capital	-2.13K
Us bancorp \de\	-2.21K
Tower research capital llc (trc)	-3.63K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	63	-4.55%	40,453,402	-2.03%	38	2.50%	21	-16.00%	21	5.00%
Mar 31, 2025	66	-16.46%	41,291,570	-7.02%	39	1.33%	25	-54.55%	20	185.71%
Dec 31, 2024	41	-16.33%	6,318,688	-63.78%	7	1.70%	27	80.00%	4	-66.67%
Sep 30, 2024	49	-2.00%	17,443,866	0.89%	21	4.75%	15	66.67%	12	-20.00%
Jun 30, 2024	50	-1.96%	17,290,686	-0.56%	21	4.32%	9	-35.71%	15	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
abrdn World Healthcare	1.85M	1.76%	-
Beleggingsfonds Hoofbosch	800.00K	0.76%	-
MEDICAL BioHealth EUR Acc	693.92K	0.66%	-
Delaware Healthcare I	620.00K	0.60%	-
Macquarie Healthcare I	620.00K	0.59%	-
Meridian Small Cap Growth Legacy	559.74K	0.53%	-
ArrowMark Small Cap Gro	559.74K	0.53%	-
Fidelity Small Cap Growth K6	249.00K	0.24%	249.00K
RIM Global Bioscience EUR	139.79K	0.13%	-
Avantis International Small Cap Val ETF	65.54K	0.06%	-

PRQR Ownership FAQ

Who Owns ProQR Therapeutics?

ProQR Therapeutics shareholders are primarily institutional investors at 38.42%, followed by 18.04% insiders and 43.54% retail investors. The average institutional ownership in ProQR Therapeutics's industry, Biotech Stocks , is 306.59%, which ProQR Therapeutics falls below.

Who owns the most shares of ProQR Therapeutics?

ProQR Therapeutics’s largest shareholders are Privium fund management b.v. (5.58M shares, 6.84%), Adage capital partners gp (6.6M shares, 6.27%), and Woodline partners lp (3.56M shares, 4.36%). Together, they hold 17.47% of ProQR Therapeutics’s total shares outstanding.

Does Blackrock own ProQR Therapeutics?

BlackRock is not among the top 10 institutional shareholders of ProQR Therapeutics.

Who is ProQR Therapeutics’s biggest shareholder by percentage of total assets invested?

M28 capital management lp is ProQR Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.55% of its assets in 1.02M ProQR Therapeutics shares, valued at 2.08M$.

Who is the top mutual fund holder of ProQR Therapeutics shares?

abrdn World Healthcare is the top mutual fund holder of ProQR Therapeutics shares, with 1.76% of its total shares outstanding invested in 1.85M ProQR Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools